GeoVax to Announce Q2 2025 Financial Results and Corporate Update

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company, will release its second quarter 2025 financial results on July 28, 2025, after the U.S. markets close. The announcement will be followed by a conference call and webcast at 4:30 p.m. ET, where management will discuss the financial outcomes and provide a corporate update. This event is crucial for stakeholders interested in GeoVax's advancements in developing vaccines and immunotherapies for infectious diseases and cancer.

Interested parties can access the live conference call by registering here, with the webcast available on GeoVax's website under the Investor Relations section. Telephone participation is also an option, requiring prior registration here. The webcast will be archived on the company's website for at least 90 days post-event, ensuring wide accessibility.